Results 151 to 160 of about 58,467 (222)

A Probe-Free Occupancy Assay to Assess a Targeted Covalent Inhibitor of Receptor Tyrosine-Protein Kinase erbB-2. [PDF]

ACS Pharmacol Transl Sci
Xue L, van Kalken D, James EM, Giammo G, Labenski MT, Cantin S, Fahnoe K, Worm K, Wang Z, Corin AF.   +9 more
europepmc   +1 more source

c-erbB-2 oncoprotein [PDF]

, 2019
openaire   +1 more source

Expression of HER2/c-erbB-2, EGFR Protein in Gastric Carcinoma and its Clinical Significance. [PDF]

Open Life Sci, 2019
Cheng G, Mei Y, Pan X, Liu M, Wu S.
europepmc   +1 more source

Evaluation of the expression of the oncogen C-ERBB-2/HER2 in advanced gastric cancer cases from Costa Rica. [PDF]

Ecancermedicalscience, 2019
Cordero-García E, Baéz-Astúa A, Roa-Martínez Y, Ramírez-Mayorga V, Alpízar-Alpízar W.   +4 more
europepmc   +1 more source

Correlation between ultrasonic features and expression levels of C-erbB-2, VEGF and nm23 in breast cancer. [PDF]

Oncol Lett, 2018
Nie M, Qin Y, Zhu J, Li Y, Wang Z.
europepmc   +1 more source

miR372 Promotes Progression of Liver Cancer Cells by Upregulating erbB-2 through Enhancement of YB-1. [PDF]

Mol Ther Nucleic Acids, 2018
Lin Z, Lu Y, Meng Q, Wang C, Li X, Yang Y, Xin X, Zheng Q, Xu J, Gui X, Li T, Pu H, Xiong W, Li J, Jia S, Lu D.   +15 more
europepmc   +1 more source

Expression of MIF and c-erbB-2 in endometrial cancer. [PDF]

Mol Med Rep, 2016
Xiao W, Dong X, Zhao H, Han S, Nie R, Zhang X, An R.   +6 more
europepmc   +1 more source